The research looked specifically at blood stem cells, which live in the bone marrow and make different types of blood cells.

The exact numbers depended on the type of medication patients took, but the risk of developing Alzheimer’s was up to 70 ...

Dr. Daniel Amen shared his BRIGHTMINDS approach for preventing Alzheimer's, addressing 11 risk factors including blood flow, ...

It's been recognized for some time that Alzheimer's disease affects brain regions differently and that tau—a protein known to ...

Alzheimer’s disease continues to rise as one of the most pressing health challenges facing aging populations today. It ...

Eli Lilly (NYSE:LLY) recently received FDA approval for a new dosing schedule of Kisunla, aimed at reducing amyloid-related ...

It's been recognized for some time that Alzheimer's disease affects brain regions differently and that tau - a protein known ...

The benefit-risk balance is tipping more in favor of Eli Lilly’s Kisunla in early Alzheimer’s disease as the FDA approves a ...